Are women living with HIV prone to osteoporosis in postmenopause? A systematic review

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author CEZARINO, Persio Yvon Adri FMUSP-HC
SIMOES, Ricardo dos Santos FMUSP-HC
BARACAT, Edmund Chadat FMUSP-HC
SOARES JUNIOR, Jose Maria FMUSP-HC
dc.date.issued 2018
dc.identifier.citation REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.64, n.5, p.469-473, 2018
dc.identifier.issn 0104-4230
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/29510
dc.description.abstract BACKGROUND: Some researchers have suggested that HIV infections can increase the cytokines, which might interfere with the bone metabolism and increase the risk of bone mass loss. However, this issue has yet to be consolidated in postmenopausal women. OBJECTIVE: To analyze studies that evaluated the loss of bone mass through DEXA in women living with HIV. MATERIALS AND METHODS: A systematic review was conducted following the PRISMA guideline. The MEDLINE, EMBASE and Cochrane databases were consulted from January 1987 to March 2017. Studies assessing bone mineral density (BMD) in postmenopausal women living with HIV were included. The secondary outcome was to evaluate the impact of antiretroviral on BMD. RESULTS: Sixty percent of the manuscripts suggested that women living with HIV had more bone loss than women in the control group, mainly in the lumbar spine. Forty percent did not observe any difference between groups. One study reported the influence of antiretroviral drugs on bone mass but did not find any difference between groups. CONCLUSION: Our data suggest that HIV infections may have a negative influence on bone mass loss in women. Further studies on the mechanism of this HIV consequence are necessary to clarify the connection as well as the impact of the antiretroviral action on BMD in postmenopausal women.
dc.language.iso eng
dc.publisher ASSOC MEDICA BRASILEIRA
dc.relation.ispartof Revista da Associacao Medica Brasileira
dc.rights openAccess
dc.subject Climacteric; Osteoporosis; HIV; Bone Density
dc.subject.other bone-mineral density; active antiretroviral therapy; infected women; immunodeficiency; prevalence; osteopenia; markers
dc.title Are women living with HIV prone to osteoporosis in postmenopause? A systematic review
dc.type article
dc.rights.holder Copyright ASSOC MEDICA BRASILEIRA
dc.description.group LIM/58
dc.identifier.doi 10.1590/1806-9282.64.05.469
dc.identifier.pmid 30304148
dc.type.category review
dc.type.version publishedVersion
hcfmusp.author CEZARINO, Persio Yvon Adri:HU:SCGINEC-62
hcfmusp.author SIMOES, Ricardo dos Santos:HC:ICHC
hcfmusp.author BARACAT, Edmund Chadat:FM:MOG
hcfmusp.author SOARES JUNIOR, Jose Maria:FM:MOG
hcfmusp.origem.id WOS:000446591800014
hcfmusp.origem.id 2-s2.0-85054883906
hcfmusp.origem.id SCIELO:S0104-42302018000500469
hcfmusp.publisher.city SAO PAULO
hcfmusp.publisher.country BRAZIL
hcfmusp.relation.reference · ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1
· Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246
· Arora Shitij, 2010, Curr Osteoporos Rep, V8, P219, DOI 10.1007/s11914-010-0036-x
· Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145
· Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660
· Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
· Calmy A, 2013, OSTEOPOROSIS INT, V24, P1843, DOI 10.1007/s00198-012-2189-1
· Cao W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20697
· Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd
· de Carvalho EH, 2010, ARQ BRAS ENDOCRINOL, V54, P133, DOI 10.1590/S0004-27302010000200008
· Dolan SE, 2004, AIDS, V18, P475, DOI 10.1097/00002030-200402200-00014
· Fonseca AM, 2010, DADOS DEMOGRAFICOS E, P23
· Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792
· Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
· Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
· Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078
· Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005
· Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109
· Ueland T, 2001, EUR J CLIN INVEST, V31, P72, DOI 10.1046/j.1365-2362.2001.00768.x
· Wells G, NEWCASTLE OTTAWA SCA
· Yin M, 2005, OSTEOPOROSIS INT, V16, P1345, DOI 10.1007/s00198-005-1845-0
dc.description.index MEDLINE
hcfmusp.citation.scopus 1
hcfmusp.citation.wos 0


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics